Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and fenretinide

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with fenretinide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Billups, C; Cabot, MC; Maurer, BJ; Melton, L; Reynolds, CP1
Corazzari, M; Di Sano, F; Donnorso, RP; Fazi, B; Hall, AG; Lovat, PE; Pearson, AD; Piacentini, M; Redfern, CP1
Abou Tayyoun, A; Abou-Lteif, G; Bazarbachi, A; Darwiche, N; Dbaibo, GS; Kozhaya, L; Najdi, T; Tayoun, AA1

Other Studies

3 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and fenretinide

ArticleYear
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Journal of the National Cancer Institute, 2000, Dec-06, Volume: 92, Issue:23

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Ceramides; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor Modulators; Fenretinide; Glucosyltransferases; Humans; Morpholines; Necrosis; Neoplasms; Protein Kinase C; Sphingosine; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
    Journal of the National Cancer Institute, 2004, Sep-01, Volume: 96, Issue:17

    Topics: Antineoplastic Agents; Apoptosis; Arachidonate 12-Lipoxygenase; Cell Line, Tumor; Ceramides; Desipramine; Enzyme Activation; Enzyme Inhibitors; Fenretinide; Flow Cytometry; Fumonisins; Gangliosides; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Humans; Morpholines; Neuroblastoma; Oxidoreductases; Reactive Oxygen Species; RNA, Small Interfering; Sphingomyelin Phosphodiesterase

2004
Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide.
    The Biochemical journal, 2005, Nov-15, Volume: 392, Issue:Pt 1

    Topics: CD4-Positive T-Lymphocytes; Cell Death; Cell Line, Transformed; Ceramides; Fenretinide; Gene Products, tax; Glucosyltransferases; Human T-lymphotropic virus 1; Humans; Morpholines

2005